ERBB2 and prostate carcinoma: As basal-like and Her2 amplified or over-expressing samples are associated with the worst prognosis of the subtypes analyzed, it is interesting to note that a recent study observed high levels of unspliced mRNA in bone metastases from castration-resistant prostate cancer relative to primary prostate cancer [20].